Literature DB >> 5061127

Inactivation of isoniazid by Canadian Eskimos and Indians.

C W Jeanes, O Schaefer, L Eidus.   

Abstract

Phenotyping for isoniazid inactivation in Canadian Eskimos and Indians showed that the former are all fast acetylators, while only 63.4% of the Indians examined belonged to the same group. Further studies are suggested to confirm this initial finding.During the investigation metabolic studies were carried out to devise a reliable urine test for phenotyping of isoniazid inactivators, to replace the fall-off technique which required venipunctures. The simplicity of the new urine test makes it suitable for mass examinations.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5061127      PMCID: PMC1940416     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  21 in total

1.  [A RAPID METHOD FOR DETERMINING THE CONCENTRATION OF INH EXCRETED THROUGH THE KIDNEYS].

Authors:  N MAIER; V MOISESCU
Journal:  Beitr Klin Tuberk Spezif Tuberkuloseforsch       Date:  1964-05-27

2.  GENETICS OF ISONIAZID METABOLISM IN CAUCASIAN, NEGRO, AND JAPANESE POPULATIONS.

Authors:  A P DUFOUR; R A KNIGHT; H W HARRIS
Journal:  Science       Date:  1964-07-24       Impact factor: 47.728

3.  Comparison of isoniazid concentrations in the blood of people of Japanese and European descent; therapeutic and genetic implications.

Authors:  H W HARRIS; R A KNIGHT; M J SELIN
Journal:  Am Rev Tuberc       Date:  1958-12

4.  [On the effect of INH metabolism on the therapy of pulmonary tuberculosis].

Authors:  H IWAINSKY; G W KAUFFMANN; D SIEGEL; C GERISCHER
Journal:  Beitr Klin Tuberk Spezif Tuberkuloseforsch       Date:  1960

5.  Clinical implications of isoniazid blood levels in pulmonary tuberculosis.

Authors:  R S MITCHELL; J C BELL
Journal:  N Engl J Med       Date:  1957-11-28       Impact factor: 91.245

6.  Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).

Authors:  A Hanngren; O Borgå; F Sjöqvist
Journal:  Scand J Respir Dis       Date:  1970

7.  Simple method for determining isoniazid acetylator phenotype.

Authors:  D W Russell
Journal:  Br Med J       Date:  1970-08-08

8.  Comparison of the isoniazid inactivation in Finns and Lapps.

Authors:  H Tiitinen; M J Mattila; A W Eriksson
Journal:  Ann Med Intern Fenn       Date:  1968

9.  [The significance of INH metabolism analysis for therapy. II].

Authors:  G Mydlak; W Volkmann
Journal:  Z Tuberk Erkr Thoraxorg       Date:  1965-11

10.  A CLINICAL STUDY OF ISONIAZID INACTIVATION.

Authors:  A G JESSAMINE; E J HAMILTON; L EIDUS
Journal:  Can Med Assoc J       Date:  1963-12-14       Impact factor: 8.262

View more
  8 in total

1.  The changing pattern of neoplastic disease in Canadian Eskimos.

Authors:  O Schaefer; J A Hildes; L M Medd; D G Cameron
Journal:  Can Med Assoc J       Date:  1975-06-21       Impact factor: 8.262

2.  The effect of thyrotoxicosis on isoniazid acetylation.

Authors:  M D Littley; A Hutchings; B P Spragg; P A Routledge; J H Lazarus
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

Review 3.  Disease and acetylation polymorphism.

Authors:  P K Lunde; K Frislid; V Hansteen
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

4.  Simplification of isoniazid phenotyping procedure to promote its application in the chemotherapy of tuberculosis.

Authors:  L Eidus; P Varughese; M M Hodgkin; A H Hsu; K B McRae
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

5.  Screening of isoniazid inactivators.

Authors:  L Eidus; M M Hodgkin
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

6.  A filter paper method for determining isoniazid acetylator phenotype.

Authors:  W W Weber; W Brenner
Journal:  Am J Hum Genet       Date:  1974-07       Impact factor: 11.025

7.  Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution.

Authors:  A K Karim; M S Elfellah; D A Evans
Journal:  J Med Genet       Date:  1981-10       Impact factor: 6.318

Review 8.  Clinical pharmacokinetics of isoniazid.

Authors:  W W Weber; D W Hein
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.